D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Lowe's Companies
LOW
|
+$591M |
| 2 |
NVIDIA
NVDA
|
+$454M |
| 3 |
EQT Corp
EQT
|
+$361M |
| 4 |
Citigroup
C
|
+$332M |
| 5 |
CELG
Celgene Corp
CELG
|
+$315M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$618M |
| 2 |
Dell
DELL
|
+$463M |
| 3 |
IBM
IBM
|
+$331M |
| 4 |
Amgen
AMGN
|
+$284M |
| 5 |
Johnson & Johnson
JNJ
|
+$250M |
Sector Composition
| 1 | Technology | 18.66% |
| 2 | Healthcare | 13.01% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Financials | 10.39% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AJRD
1401
DELISTED
Aerojet Rocketdyne Holdings, Inc.
AJRD
| $2.3M | ﹤0.01% |
82,268
+3,804
| +5% | +$106K |
|
|
ESL
1402
DELISTED
Esterline Technologies
ESL
| $2.3M | ﹤0.01% |
+31,454
| New | +$2.3M |
|
1403
Houlihan Lokey
HLI
$14.1B
| $2.3M | ﹤0.01% |
51,478
-24,964
| -33% | -$1.11M |
|
|
DF
1404
DELISTED
Dean Foods Company
DF
| $2.3M | ﹤0.01% |
266,281
-416,395
| -61% | -$3.59M |
|
1405
Wave Life Sciences
WVE
$1.14B
| $2.29M | ﹤0.01% |
57,052
+50,610
| +786% | +$2.03M |
|
|
SPA
1406
DELISTED
Sparton
SPA
| $2.28M | ﹤0.01% |
131,207
+96,812
| +281% | +$1.69M |
|
1407
uniQure
QURE
$929M
| $2.28M | ﹤0.01% |
97,044
-9,398
| -9% | -$221K |
|
1408
Angi Inc
ANGI
$769M
| $2.27M | ﹤0.01% |
16,680
-8,000
| -32% | -$1.09M |
|
|
GPX
1409
DELISTED
GP Strategies Corp.
GPX
| $2.26M | ﹤0.01% |
99,903
+13,850
| +16% | +$314K |
|
1410
Woodward
WWD
$14.4B
| $2.26M | ﹤0.01% |
31,512
-37,818
| -55% | -$2.71M |
|
1411
Old National Bancorp
ONB
$8.81B
| $2.25M | ﹤0.01% |
132,966
+62,080
| +88% | +$1.05M |
|
1412
ProAssurance
PRA
$1.22B
| $2.24M | ﹤0.01% |
46,193
+29,959
| +185% | +$1.45M |
|
|
TIVO
1413
DELISTED
Tivo Inc
TIVO
| $2.24M | ﹤0.01% |
165,240
-294,016
| -64% | -$3.98M |
|
1414
Dillards
DDS
$8.88B
| $2.23M | ﹤0.01% |
27,791
+14,541
| +110% | +$1.17M |
|
1415
CytomX Therapeutics
CTMX
$345M
| $2.21M | ﹤0.01% |
77,515
+47,034
| +154% | +$1.34M |
|
1416
Boston Properties
BXP
$11.7B
| $2.2M | ﹤0.01% |
17,888
-6,677
| -27% | -$823K |
|
1417
Seres Therapeutics
MCRB
$154M
| $2.2M | ﹤0.01% |
15,015
-4,007
| -21% | -$588K |
|
1418
Ryanair
RYAAY
$31.1B
| $2.2M | ﹤0.01% |
44,765
+32,450
| +263% | +$1.59M |
|
1419
Omnicell
OMCL
$1.53B
| $2.2M | ﹤0.01% |
50,576
+32,238
| +176% | +$1.4M |
|
1420
Matsons
MATX
$3.28B
| $2.19M | ﹤0.01% |
76,468
+8,152
| +12% | +$233K |
|
|
MITL
1421
DELISTED
Mitel Networks Corporation
MITL
| $2.18M | ﹤0.01% |
235,335
-540,622
| -70% | -$5.02M |
|
1422
Clearwater Paper
CLW
$342M
| $2.18M | ﹤0.01% |
55,769
-31,589
| -36% | -$1.24M |
|
1423
Federated Hermes
FHI
$4.1B
| $2.17M | ﹤0.01% |
65,098
-142,494
| -69% | -$4.76M |
|
1424
Extreme Networks
EXTR
$3.02B
| $2.17M | ﹤0.01% |
196,246
-1,115,916
| -85% | -$12.4M |
|
1425
Novartis
NVS
$247B
| $2.16M | ﹤0.01% |
+29,856
| New | +$2.16M |
|